COL8A2 Regulates the Fate of Corneal Endothelial Cells

Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):26. doi: 10.1167/iovs.61.11.26.

Abstract

Purpose: To investigate the effect of COL8A2 repression on corneal endothelial cells (CECs) in vitro and in vivo.

Methods: Cultured human CECs (hCECs) were transfected with COL8A2 siRNA (siCOL8A2), and the cell viability and proliferation rate were measured. The expression of cell proliferation-associated molecules was evaluated by Western blotting and real-time reverse transcription PCR. Cell shape, Wingless-INT (WNT) signaling, and mitochondrial oxidative stress were also measured. For in vivo experiments, siCOL8A2 was transfected into rat CECs (rCECs), and corneal opacity and corneal endothelium were evaluated.

Results: After transfection with siCOL8A2, COL8A2 expression was reduced (80%). Cell viability, cell proliferation rate, cyclin D1 expression, and the number of cells in the S-phase were reduced in siCOL8A2-treated cells. The cell attained a fibroblast-like shape, and SNAI1, pSMAD2, and β-catenin expression, along with mitochondrial mass and oxidative stress levels, were altered. Corneal opacity increased, and the CECs were changed in rats in the siCOL8A2 group.

Conclusions: COL8A2 is required to maintain normal wound healing and CEC function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Proliferation
  • Cells, Cultured
  • Collagen Type VIII / biosynthesis
  • Collagen Type VIII / genetics*
  • Corneal Opacity / genetics
  • Corneal Opacity / metabolism*
  • Corneal Opacity / pathology
  • Disease Models, Animal
  • Endothelium, Corneal / metabolism*
  • Endothelium, Corneal / pathology
  • Gene Expression Regulation*
  • RNA / genetics*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • COL8A2 protein, human
  • Collagen Type VIII
  • RNA